Immetacyte Ltd: Clinical Trials

1 trial sponsored by Immetacyte Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Immetacyte Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial)
cyclophosphamide, fludarabine, IL-2 (Proleukin) - Ovarian Cancer Metastatic
Phase 1 / Phase 2WithdrawnImmetacyte Ltd2020-07-012020-12-16

Interventions

Cyclophosphamide (1)  ·  Interleukin-2 (1)  ·  aldesleukin (1)  ·  fludarabine (1)

Countries

United Kingdom (1)

Top investigators

Fiona Thistlethwaite, PhD, MRCP (1)

NIH funding

2019 (1)